In this study, a tumor acidity-responsive ferroptosis-inducing microreactor was concisely prepared by encapsulating LOX within LPE stabilized in combination with pH-dissociable CaCO3 nanoparticles and hemin, thus enabling proof-of-concept TAFE therapy of HCC tumors. This evidence concerns the gene LOX and neoplasm.